Hepatic encephalopathy in our genes?

Annals of Internal Medicine

Volumn 153, Issue 5, 2010, Pages 335-336

  Albrecht, Jan ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMMONIA; GLUTAMINASE; GLUTAMINE;

AMINO ACID SYNTHESIS; DIABETES MELLITUS; EDITORIAL; GENE MUTATION; GENETIC TRANSFECTION; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER INJURY; MICROSATELLITE MARKER; MORTALITY; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROMOTER REGION; TRAFFIC ACCIDENT; ENZYMOLOGY; GENETICS; MUTATION; NOTE;

GLUTAMINASE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MUTATION; PROMOTER REGIONS, GENETIC;

EID: 77956703896     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-5-201009070-00008     Document Type: Editorial

References (20)

1. Albrecht J, Jones EA. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci. 1999;170:138-46. [PMID: 10617392]
2. Eurostat. Accessed at http://ec.europa.eu/health/ph-information/ dissemination/echi/echi-en.htm on 26 July 2010.
3. Leevy CB, Phillips JA. Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy. Dig Dis Sci. 2007;52:737-41. [PMID: 17245628]
4. Quero JC, Schalm SW. Subclinical hepatic encephalopathy. Semin Liver Dis. 1996;16:321-8. [PMID: 8989817]
5. Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol. 2000;95:2029-34. [PMID: 10950053]
6. Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718-23. [PMID: 11569701]
7. Romero-Gómez M, Jover M, Del Campo JA, Royo JL, Hoyas E, Galán JJ, et al. Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis. A cohort study. Ann Intern Med. 2010;153:281-8.
8. Als-Nielsen B, Gluud LL, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ. 2004;328:1046. [PMID: 15054035]
9. Romero-Gómez M, Grande L, Camacho I, Benitez S, Irles JA, Castro M. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol. 2002;37:781-7. [PMID: 12445419] (Pubitemid 35404217)
10. Romero-Gómez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology. 2004;39:939-43. [PMID: 15057897] (Pubitemid 38428932)
11. Romero-Gómez M, Ramos-Guerrero R, Grande L, de Terán LC, Corpas R, Camacho I, et al. Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. J Hepatol. 2004;41:49-54. [PMID: 15246207] (Pubitemid 39005152)
12. Olde Damink SW, Jalan R, Deutz NE, Redhead DN, Dejong CH, Hynd P, et al. The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis. Hepatology. 2003;37:1277-85. [PMID: 12774005] (Pubitemid 36667306)
13. Elgadi KM, Meguid RA, Qian M, Souba WW, Abcouwer SF. Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics. 1999;1:51-62. [PMID: 11015561] (Pubitemid 129622451)
14. Aledo JC, Gómez-Fabre PM, Olalla L, Márquez J. Identification of two human glutaminase loci and tissue-specific expression of the two related genes. Mamm Genome. 2000;11:1107-10. [PMID: 11130979]
15. Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology. 2006;44:788-94. [PMID: 17006913] (Pubitemid 46489541)
16. Bak LK, Schousboe A, Waagepetersen HS. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem. 2006;98:641-53. [PMID: 16787421] (Pubitemid 44051266)
17. Cauli O, Rodrigo R, Llansola M, Montoliu C, Monfort P, Piedrafita B, et al. Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab Brain Dis. 2009;24:69-80. [PMID: 19085094]
18. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004;40:247-54. [PMID: 14739095] (Pubitemid 38115829)
19. Rama Rao KV, Reddy PV, Tong X, Norenberg MD. Brain edema in acute liver failure: inhibition by L-histidine. Am J Pathol. 2010;176:1400-8. [PMID: 20075201]
20. Stravitz RT, Lee WM, Kramer AH, Kramer DJ, Hynan L, Blei AT. Therapeutic hypothermia for acute liver failure: toward a randomized, controlled trial in patients with advanced hepatic encephalopathy. Neurocrit Care. 2008;9:90-6. [PMID: 18389180]